Ensuring Day 1 Readiness for Innovative Oncology Therapy

Even though they had an existing channel data aggregator, this manufacturer was still struggling with a number of market access issues including:

  • Poor channel data was impacting accurate payment of field compensation
  • Weak data mastering led to duplicate and distrusted data
  • Lack of real-time insight into channel and business performance
  • Channel data overload
  • Potential revenue leakage.

Learn how IntegriChain helped. Download below!

Rg Casestudy
adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article